Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma

Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model

(2015) F Yang et al.   Cell Death & Disease

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors

(2015) Daniel Zingg et al.   Nature Communications

Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells

(2015) Wei Cao et al.   Scientific Reports

Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis

(2014) Tinghong Ye et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo

(2014) Yong Xia et al.   CANCER LETTERS

Mitogen-activated Protein Kinase (MAPK) Hyperactivation and Enhanced NRAS Expression Drive Acquired Vemurafenib Resistance in V600E BRAF Melanoma Cells

(2014) Michael Lidsky et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The cancer that rises with the Sun

(2014) David Holmes   NATURE

The malignant melanoma landscape

(2014) Rachel M. Webster et al.   NATURE REVIEWS DRUG DISCOVERY

Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal −/− mice

(2014) T Zhao et al.   ONCOGENE

Epidemiology, Risk Factors, Prevention, and Early Detection of Melanoma

(2014) Saïd C. Azoury et al.   SURGICAL CLINICS OF NORTH AMERICA

SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway

(2014) X Peng et al.   Cell Death & Disease

YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models

(2014) Yong Xia et al.   Scientific Reports

Stat3-Targeted Therapies Overcome the Acquired Resistance to Vemurafenib in Melanomas

(2013) Fang Liu et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma

(2013) Howard L. Kaufman et al.   Nature Reviews Clinical Oncology

Why is melanoma so metastatic?

(2013) Russell R. Braeuer et al.   Pigment Cell & Melanoma Research

A Landscape of Driver Mutations in Melanoma

(2012) Eran Hodis et al.   CELL

Photooxidation of Amplex red to resorufin: Implications of exposing the Amplex red assay to light

(2012) Baozhong Zhao et al.   FREE RADICAL BIOLOGY AND MEDICINE

Both miR-17-5p and miR-20a Alleviate Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating STAT3 Expression

(2011) M. Zhang et al.   JOURNAL OF IMMUNOLOGY

Vemurafenib

(2011) Keith. T Flaherty et al.   NATURE REVIEWS DRUG DISCOVERY

The Role of Mitochondria in Apoptosis

(2009) Chunxin Wang et al.   Annual Review of Genetics

Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3

(2008) E. A. Nelson et al.   BLOOD

A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells

(2008) L.-Y. Kong et al.   CLINICAL CANCER RESEARCH